Brain, Vol. 125, No. 11, 2408-2417,
November 2002
© 2002 Oxford University Press
Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation
1 Department of Clinical and Biological Neurosciences and INSERM U318, Joseph Fourier University, CHU de Grenoble, Grenoble, France, 2 Department of Neurology, Niguarda Ca’ Granda Hospital, Milan, Italy and 3 Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
Correspondence to: Pierre Pollak, Department of Clinical and Biological Neurosciences, Joseph Fourier University of Grenoble, CHU, Service de Neurologie, BP 217 38043 Grenoble, France E-mail: pierre.pollak{at}ujf-grenoble.fr
The response to levodopa changes over time in Parkinson’s disease, probably due to alterations in the dopaminergic system, progression of the disease and pulsatile oral intake of the drug. Bilateral high-frequency stimulation of the subthalamic nucleus (STN) allows a large reduction or the complete cessation of levodopa intake in patients with advanced Parkinson’s disease. We studied variation in the motor short-duration response (SDR) during a levodopa challenge in bilaterally STN-stimulated patients. Twenty-eight consecutive patients with a mean duration of Parkinson’s disease of 16.6 ± 6.0 years at the time of surgery were enrolled. Fourteen patients were evaluated both before STN stimulation and 3 months after surgery (group 1) whereas the other 14 patients were assessed before implantation and after a mean of 3 years of STN stimulation (group 2). After drug withdrawal for one night, the hand-tapping test (TT) was carried out every 15 min, together with evaluation of dyskinesias using a modified Goetz scale. The Unified Parkinson’s Disease Rating Scale (UPDRS) motor score was assessed every 30 min. In operated patients, STN stimulation was stopped 15 min before starting the clinical evaluations. A suprathreshold oral levodopa dose was given after one motor evaluation and two TTs. The clinical evaluation was carried out until the TT score returned to the baseline. In group 1, six patients continued without levodopa after surgery and the other eight received a daily mean dose of 337 mg; in group 2, seven patients continued without levodopa and the other seven received a daily mean dose of 386 mg. The main change in the levodopa SDR was a significant reduction in levodopa-induced dyskinesias in both groups. In those patients of group 1 who did not receive levodopa after surgery, the motor UPDRS magnitude decreased and the ‘on’ UPDRS motor score worsened. In group 2, the results were similar, but in the patients who continued to receive levodopa after surgery the TT magnitude increased. On the whole, chronic bilateral STN stimulation tended to decrease the magnitude of the levodopa SDR without changing the duration and latency of the response. These results suggest that continuous STN stimulation induces long-term plastic changes of the dopaminergic system, with slow and partial desensitization. In addition, the persistence of levodopa intake after surgery might hinder this beneficial process.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. C. M. Poon and M. G. Irwin Anaesthesia for deep brain stimulation and in patients with implanted neurostimulator devices Br. J. Anaesth., August 1, 2009; 103(2): 152 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Weinberger, W. D. Hutchison, A. M. Lozano, M. Hodaie, and J. O. Dostrovsky Increased Gamma Oscillatory Activity in the Subthalamic Nucleus During Tremor in Parkinson's Disease Patients J Neurophysiol, February 1, 2009; 101(2): 789 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sailer, D. I. Cunic, G. O. Paradiso, C. A. Gunraj, A. Wagle-Shukla, E. Moro, A. M. Lozano, A. E. Lang, and R. Chen Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease Neurology, January 30, 2007; 68(5): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Weinberger, N. Mahant, W. D. Hutchison, A. M. Lozano, E. Moro, M. Hodaie, A. E. Lang, and J. O. Dostrovsky Beta Oscillatory Activity in the Subthalamic Nucleus and Its Relation to Dopaminergic Response in Parkinson's Disease J Neurophysiol, December 1, 2006; 96(6): 3248 - 3256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Dagtekin, T. Berlet, H. J. Gerbershagen, M. Dueck, and T. Giesecke Anesthesia and deep brain stimulation: postoperative akinetic state after replacement of impulse generators. Anesth. Analg., September 1, 2006; 103(3): 784 - 784. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Moro, Y.-Y. W. Poon, A. M. Lozano, J. A. Saint-Cyr, and A. E. Lang Subthalamic Nucleus Stimulation: Improvements in Outcome With Reprogramming Arch Neurol, September 1, 2006; 63(9): 1266 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wider, H. Russmann, J.-G. Villemure, B. Robert, J. Bogousslavsky, P. R. Burkhard, and F. J. G. Vingerhoets Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Arch Neurol, July 1, 2006; 63(7): 951 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Maurer, T. Mergner, J. Xie, M. Faist, P. Pollak, and C. H. Lucking Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease Brain, May 1, 2003; 126(5): 1146 - 1163. [Abstract] [Full Text] [PDF]
|
|